Skip to main content

Books in Microbiology and virology

Elsevier's Microbiology & Virology collection provides comprehensive coverage of viruses and microorganisms, addressing their impact on human, animal, and plant health. It includes topics such as prevention, treatment, and research of viral diseases like coronaviruses, flaviviruses, and viral hemorrhagic fevers. The collection delves into fields like Bacteriology, Mycology, and Microbial genetics, focusing on their roles in environmental, agricultural, and health-related contexts. This resource serves as a vital tool for scientists, facilitating the study of viruses and microorganisms and enabling the development of effective strategies for infectious disease prevention, diagnosis, and control.

    • Advances in Parasitology

      • 1st Edition
      • Volume 129
      • October 1, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 3 4 6 3 9 2
      • eBook
        9 7 8 0 4 4 3 3 4 6 4 0 8
      Unveiling the Proteolytic Networks of Parasites, Volume 129 in the Advances in Parasitology series, presents a cutting-edge exploration of specific proteases across a spectrum of parasitic organisms. Top researchers in the field conduct multifaceted examinations, shedding light on the distinct roles of these proteases within significant parasite groups, including malaria, trematodes, nematodes, and blood-feeding arthropods. Chapters in this new release include The roundworm Ascaris: recent advances and progress towards elimination, Genetically modified helminths as pharmaceutical bio-factories, Epithelial cytokines in helminth infections, Schistosoma eggs: from conception to eggs-creation, Helminth extracellular vesicles: roles in and beyond parasite-host communication, and more.
    • Leveraging Viruses for the Treatment of Viral Diseases and Cancer

      • 1st Edition
      • October 31, 2025
      • Tibor Bakacs
      • English
      Leveraging Viruses for the Treatment of Viral Diseases and Cancer: Improving Host Fitness by Combinations of Virus and Host Genes gives a comprehensive overview on the impact of using naturally or intentionally attenuated viruses - which are apathogenic to people - to control viral diseases and cancer. It examines the potential of exploiting, developing, and using apathogenic viruses as therapeutic tools. Sections cover the COVID-19 pandemic and the need for a post-Infection Plan B to combat SARS-CoV-2 infections as gaps in testing and vaccination create the perfect conditions for a new variant of concern to emerge.More generally, the book also provides specific examples of the use of apathogenic viruses to treat other infectious diseases. It discusses the process of manufacturing viral therapies and how infectious disease treatments can be repurposed to improve other therapies like for cancer. With contribution from an international group of contributors, Leveraging Viruses for the Treatment of Viral Diseases and Cancer is useful references for those engages in study and development of infectious diseases and ways to combat them.
    • Biosafety Level 4 (BSL4) – Virus Research at the Highest Level of Biosafety and Biosecurity

      • 1st Edition
      • Volume 121
      • May 17, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 3 4 2 9 8 1
      • eBook
        9 7 8 0 4 4 3 3 4 2 9 9 8
      Biosafety Level 4 (BSL4) – Virus Research at the Highest Level of Biosafety and Biosecurity, Volume 121 highlights new advances, with this new volume presenting interesting chapters on highly important topics such as Molecular virulence determinants of human-pathogenic filoviruses, Mucosal Sudan virus infection results in a lethal disease in ferrets with previous Lloviu virus infection not providing cross-protection, Transcriptional signatures of Ebola and Marburg virus infection in a Bat-Immune-System (BIS) mouse model, Divergences in the microbial inactivation pattern between vaporized hydrogen peroxide and aerosolized peracetic acid by dry fogging, and much more.Other chapters cover Molecular expressions in tissues and blood following Reston and Bundibugyo virus infection in swine, De novo rescue of new BSL4 henipaviruses - from sequence to pathogen, Semi-automated diagnostic RT-PCR as a screening assay for antiviral compounds in a 96-well format against highly pathogenic RNA viruses, and Relevance of studying virus – natural reservoir interactions: SNV in deer mice and LASV in Mastomys natalensis.
    • Microbial Stress Survival

      • 1st Edition
      • December 1, 2025
      • Ashutosh Kumar
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 6 2 2 4
      • eBook
        9 7 8 0 4 4 3 2 7 6 2 3 1
      Microbial Stress Survival explores the diversity of microbes, the microbe-host relationship, and the various strategies employed by microbes that enable them to adapt to stressful environments and persist in hostile conditions. The book aims to cover critical pathogen biology, microbial adaptation and survival strategies, and the impact of microbial resilience on therapeutic efforts. Topics include the modulation of host pathways by pathogens for their adaptation and survival; their drug tolerance and antimicrobial resistance; role of proteins in microbial stress survival; and evolutionary adaptative mechanisms of extremophiles. Microbial Stress Survival is an insightful resource for those interested in pathogen biology and the different adaptive features and resilience of microbes.
    • Navigating Endophytic Research for Next-Generation Therapeutics

      • 1st Edition
      • February 17, 2025
      • Vagish Dwibedi + 3 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 1 4 8 4 1
      • eBook
        9 7 8 0 4 4 3 3 1 4 8 5 8
      Navigating Endophytic Research for Next-Generation Therapeutics explores the evolving field of endophytic fungal research and applications in combating diseases, addressing environmental challenges, and in shaping the future of therapeutics. The book starts off with a discussion on the biodiversity and biogeography of endophytic fungal communities and describes the bioprospecting of endophytes for drug discovery. In addition, it covers the therapeutic application of endophytic fungi to treat and manage specific diseases and investigates the innovative use of technologies such as genome editing, genetic engineering for enhanced bioactivity, multi-omics-based exploration, and the use of big data and machine learning in endophytic drug discovery.Featuring contributions from experts across fields like mycology, pharmacology, biotechnology, and environment science, this comprehensive, practical, and insightful resource guides those engaged in endophytic fungal research and its transformative potential in next-generation therapeutics.
    • Handbook of Immunoassay Technologies

      • 2nd Edition
      • February 4, 2025
      • Sandeep K. Vashist + 1 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 5 5 0 9 6
      • eBook
        9 7 8 0 3 2 3 9 5 5 1 0 2
      Handbook of Immunoassay Technologies: Approaches, Performances, and Applications, Second Edition unravels the role of immunoassays in the biochemical sciences. During the last four decades, a wide range of immunoassays has been developed, ranging from the conventional enzyme-linked immunosorbent assays to the smartphone-based point-of-care formats. The book discusses how advances in rapid biochemical procedures, novel biosensing schemes, fully integrated lab-on-a-chip platforms, prolonged biomolecular storage strategies, device miniaturization and interfacing, and emerging smart system technologies that have paved the way for next-generation immunoassays.Revised and updated, the second edition of Handbook of Immunoassay Technologies: Approaches, Performances, and Applications covers all the relevant, timely, and important developments in the field. This edition offers new content on topics such as antibody production for immunodiagnostics, multiplex immunoassays, chemiluminescent immunoassays, immunoassays for newborn screening, and immunoassays of viruses like SARS-CoV-2, HIV, Ebola, and Hepatitis C. The addition of these new topics as well as up-to-date content make the second edition a valuable and comprehensive resource on immunoassays.
    • Adenoviral Vectors for Gene Therapy

      • 3rd Edition
      • April 9, 2025
      • David T. Curiel + 1 more
      • English
      • Hardback
        9 7 8 0 3 2 3 8 9 8 2 1 8
      • eBook
        9 7 8 0 3 2 3 9 5 8 1 4 1
      Adenoviral Vectors for Gene Therapy, Third Edition, provides detailed, comprehensive coverage of gene delivery vehicles based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, as platforms for gene therapy and gene editing, as well as for oncology approaches, making them class leading agents in the gene-advanced therapies arena.The fully updated and expanded third edition covers the basic biology of adenoviruses and highlights the potential use of adenoviral vectors for the treatment of disease, including their construction, propagation, and purification, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models. The book also considers the regulatory issues surrounding human clinical gene therapy trials. New chapters include adenoviral vaccines for veterinary applications, adenoviruses for gene editing, nonhuman primate adenoviruses, COVID-19 vaccines, vaccine applications, and oncolytic adenoviruses for antitumor immunization. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.
    • Trichomonas vaginalis

      • 1st Edition
      • January 21, 2025
      • Prashant Khare + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 2 2 0 4 7
      • eBook
        9 7 8 0 4 4 3 2 2 2 0 5 4
      Trichomonas Vaginalis: Pathogenesis, Diagnosis, and Treatment provides up-to-date knowledge about Trichomoniasis, the most prevalent and neglected non-viral sexually transmitted infection that can result in compromised reproductive health. The book discusses its epidemiology, the pathogenesis of disease, the mechanisms involved in the host immune response, clinical manifestations, and its impact on reproductive health. In addition, it also describes the new insights and challenges involved in the identification of promising drug targets and examines current diagnostic tools and therapies against Trichomonas vaginalis infection.In summary, the book provides comprehensive coverage of this neglected protozoan parasite and the sexually transmitted infection it causes. It is a valuable resource to researchers and scientists who are working on male and female reproductive disorders caused by Trichomonas vaginalis.
    • Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases

      • 1st Edition
      • February 14, 2025
      • Anoop Kumar + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 8 8 3 6 4
      • eBook
        9 7 8 0 4 4 3 2 8 8 3 7 1
      Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases discusses how nanotechnology aids in overcoming the existing traditional approaches in combating diseases. The book explores the emerging trends of using nanoparticles for nanotherapeutics and nanotheranostics and their role in the efficient diagnosis and treatment of infectious microbial diseases. Sections covers nanotherapeutic impregnated medical devices, nanotherapeutics as vaccines, related regulatory requirements, the application of nanotherapeutics and nanotheranostics in diagnosing and treating specific infectious diseases, including bacterial infections, viral infections, fungal infestations, parasitic infestations, and other infectious conditions.With chapter contributions from experts in the fields, this book offers a comprehensive reference for researchers, scientists, and industry professionals working on infectious diseases and the application of nanoparticles to effectively diagnose, treat, and manage them.
    • Brave Genomes

      • 1st Edition
      • February 25, 2025
      • Silvia Bulgheresi
      • English
      • Paperback
        9 7 8 0 4 4 3 1 8 7 8 9 6
      • eBook
        9 7 8 0 4 4 3 1 8 7 8 8 9
      The role of environmentally triggered genetic and epigenetic changes in microbial adaptation and evolution is still not broadly appreciated. Brave Genomes: Microbial Genome Plasticity in the Face of Environmental Challenge narrates how microorganisms cope with environmental changes including unanticipated ones. Although it does comprise eukaryotes, it focuses on bacteria and – whenever possible – on archaea.Among the environmentally sensitive sources of genome plasticity, the book treats tandem repeats, mutagenic break repair, transcription-associ... mutagenesis and transposable elements. Additionally, it deals with epigenetic mechanisms such as DNA methylation and regulatory RNA-based systems. These not only regulate the activity of mobile DNA, they can also synergize with it. In closing, symbiosis and genetic noise are also discussed as possible sources of phenotypic plasticity.Brave Genomes emphasizes the role of the environment in generating genotypic and phenotypic diversity. This emerges, in turn, as the most efficient response to challenging conditions.